Loading patent…
AssigneeUniversity College Cardiff Consultants Limited
InventorsPeter Ghazal, Paul Dickinson, Thorsten Forster, Claire Smith, Ben Stenson, Mizan Khondoker
Estimating the term…
Sepsis remains a leading cause of morbidity and mortality in neonates worldwide. There is also clinically a low threshold for suspicion of infection in neonates, in particular as presentation varies greatly from very subtle to catastrophic collapse. The lack of reliably sensitive tests and the potential life-threatening consequences of delayed treatment of infection results in the widespread use of empirical antibiotics exposing many infants without infection to broad-spectrum antibiotics. The present invention provides a series of patient-invariant biomarkers for screening neonates and other subjects for infection that predicts bacterial infection with high accuracy; and is further shown to have predictive value in identifying infection in suspected cases with blood-culture negative tests.
A method of diagnosing and treating sepsis in a human subject, the method comprising the steps of:
Dependencies are inferred from the claim text.